207 related articles for article (PubMed ID: 19768675)
1. A comparison of uptake of metformin and phenformin mediated by hOCT1 in human hepatocytes.
Sogame Y; Kitamura A; Yabuki M; Komuro S
Biopharm Drug Dispos; 2009 Nov; 30(8):476-84. PubMed ID: 19768675
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the kinetic characteristics of inhibitory effects exerted by biguanides and H2-blockers on human and rat organic cation transporter-mediated transport: Insight into the development of drug candidates.
Umehara KI; Iwatsubo T; Noguchi K; Kamimura H
Xenobiotica; 2007 Jun; 37(6):618-34. PubMed ID: 17614008
[TBL] [Abstract][Full Text] [Related]
3. Involvement of organic cation transporter 1 in hepatic and intestinal distribution of metformin.
Wang DS; Jonker JW; Kato Y; Kusuhara H; Schinkel AH; Sugiyama Y
J Pharmacol Exp Ther; 2002 Aug; 302(2):510-5. PubMed ID: 12130709
[TBL] [Abstract][Full Text] [Related]
4. Liver uptake of biguanides in rats.
Sogame Y; Kitamura A; Yabuki M; Komuro S
Biomed Pharmacother; 2011 Sep; 65(6):451-5. PubMed ID: 21880461
[TBL] [Abstract][Full Text] [Related]
5. Transport of biguanides by human organic cation transporter OCT2.
Sogame Y; Kitamura A; Yabuki M; Komuro S; Takano M
Biomed Pharmacother; 2013 Jun; 67(5):425-30. PubMed ID: 23582785
[TBL] [Abstract][Full Text] [Related]
6. Transport of guanidine compounds by human organic cation transporters, hOCT1 and hOCT2.
Kimura N; Masuda S; Katsura T; Inui K
Biochem Pharmacol; 2009 Apr; 77(8):1429-36. PubMed ID: 19426682
[TBL] [Abstract][Full Text] [Related]
7. Effects of tetraalkylammonium compounds with different affinities for organic cation transporters on the pharmacokinetics of metformin.
Choi MK; Jin QR; Jin HE; Shim CK; Cho DY; Shin JG; Song IS
Biopharm Drug Dispos; 2007 Dec; 28(9):501-10. PubMed ID: 17876861
[TBL] [Abstract][Full Text] [Related]
8. Biguanide-induced mitochondrial dysfunction yields increased lactate production and cytotoxicity of aerobically-poised HepG2 cells and human hepatocytes in vitro.
Dykens JA; Jamieson J; Marroquin L; Nadanaciva S; Billis PA; Will Y
Toxicol Appl Pharmacol; 2008 Dec; 233(2):203-10. PubMed ID: 18817800
[TBL] [Abstract][Full Text] [Related]
9. Transport of dicationic drugs pentamidine and furamidine by human organic cation transporters.
Ming X; Ju W; Wu H; Tidwell RR; Hall JE; Thakker DR
Drug Metab Dispos; 2009 Feb; 37(2):424-30. PubMed ID: 18971316
[TBL] [Abstract][Full Text] [Related]
10. Functional characterization of the human organic cation transporter 2 variant p.270Ala>Ser.
Zolk O; Solbach TF; König J; Fromm MF
Drug Metab Dispos; 2009 Jun; 37(6):1312-8. PubMed ID: 19251820
[TBL] [Abstract][Full Text] [Related]
11. Functional involvement of organic cation transporter1 (OCT1/Oct1) in the hepatic uptake of organic cations in humans and rats.
Umehara KI; Iwatsubo T; Noguchi K; Kamimura H
Xenobiotica; 2007 Aug; 37(8):818-31. PubMed ID: 17701831
[TBL] [Abstract][Full Text] [Related]
12. Organic cation transporter 1 mediates the uptake of monocrotaline and plays an important role in its hepatotoxicity.
Tu M; Sun S; Wang K; Peng X; Wang R; Li L; Zeng S; Zhou H; Jiang H
Toxicology; 2013 Sep; 311(3):225-30. PubMed ID: 23831208
[TBL] [Abstract][Full Text] [Related]
13. The human organic cation transporter-1 gene is transactivated by hepatocyte nuclear factor-4alpha.
Saborowski M; Kullak-Ublick GA; Eloranta JJ
J Pharmacol Exp Ther; 2006 May; 317(2):778-85. PubMed ID: 16436500
[TBL] [Abstract][Full Text] [Related]
14. Differential substrate and inhibitory activities of ranitidine and famotidine toward human organic cation transporter 1 (hOCT1; SLC22A1), hOCT2 (SLC22A2), and hOCT3 (SLC22A3).
Bourdet DL; Pritchard JB; Thakker DR
J Pharmacol Exp Ther; 2005 Dec; 315(3):1288-97. PubMed ID: 16141367
[TBL] [Abstract][Full Text] [Related]
15. Role of organic cation/carnitine transporter 1 in uptake of phenformin and inhibitory effect on complex I respiration in mitochondria.
Shitara Y; Nakamichi N; Norioka M; Shima H; Kato Y; Horie T
Toxicol Sci; 2013 Mar; 132(1):32-42. PubMed ID: 23221006
[TBL] [Abstract][Full Text] [Related]
16. Regulation of the human organic cation transporter hOCT1.
Ciarimboli G; Struwe K; Arndt P; Gorboulev V; Koepsell H; Schlatter E; Hirsch JR
J Cell Physiol; 2004 Dec; 201(3):420-8. PubMed ID: 15389554
[TBL] [Abstract][Full Text] [Related]
17. Identification of human metabolites of (-)-N-{2-[(R)-3-(6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline-2-carbonyl)piperidino]ethyl}-4-fluorobenzamide (YM758), a novel If channel inhibitor, and investigation of the transporter-mediated renal and hepatic excretion of these metabolites.
Umehara K; Shirai N; Iwatsubo T; Noguchi K; Usui T; Kamimura H
Drug Metab Dispos; 2009 Aug; 37(8):1646-57. PubMed ID: 19439489
[TBL] [Abstract][Full Text] [Related]
18. Interaction of Ethambutol with human organic cation transporters of the SLC22 family indicates potential for drug-drug interactions during antituberculosis therapy.
Pan X; Wang L; Gründemann D; Sweet DH
Antimicrob Agents Chemother; 2013 Oct; 57(10):5053-9. PubMed ID: 23917312
[TBL] [Abstract][Full Text] [Related]
19. Functional characterization of an organic cation transporter (hOCT1) in a transiently transfected human cell line (HeLa).
Zhang L; Schaner ME; Giacomini KM
J Pharmacol Exp Ther; 1998 Jul; 286(1):354-61. PubMed ID: 9655880
[TBL] [Abstract][Full Text] [Related]
20. Relevance of the OCT1 transporter to the antineoplastic effect of biguanides.
Segal ED; Yasmeen A; Beauchamp MC; Rosenblatt J; Pollak M; Gotlieb WH
Biochem Biophys Res Commun; 2011 Nov; 414(4):694-9. PubMed ID: 21986525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]